| Dr Scott Nodzo, MD | |
|
4949 Harlem Rd, Amherst, NY 14226-2500 | |
| (716) 204-3200 | |
| Not Available |
| Full Name | Dr Scott Nodzo |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 14 Years |
| Location | 4949 Harlem Rd, Amherst, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225356074 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 16755 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mcauley Seton Home Care Corp Chha | Buffalo, NY | Home health agency |
| Vna Of Western Ny Chha | Williamsville, NY | Home health agency |
| Sisters Of Charity Hospital | Buffalo, NY | Hospital |
| Erie County Medical Center | Buffalo, NY | Hospital |
| Mercy Hospital Of Buffalo | Buffalo, NY | Hospital |
| Wyoming County Community Hospital | Warsaw, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Orthopaedic Services Inc. | 7810983004 | 102 |
News Archive
Bristol-Myers Squibb (NYSE: BMY) and Enterome SA (Enterome), a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome, announced that they have entered into an Immuno-Oncology focused collaboration agreement for the discovery and development of microbiome-derived biomarkers, drug targets and bioactive molecules to be developed as potential companion diagnostics and therapeutics for cancer.
Researchers at Beth Israel Deaconess Medical Center (BIDMC) have found that a triple combination therapy consisting of both tolerance-inducing and anti-inflammatory properties is successful in abolishing adverse autoimmunity against insulin-producing cells in a mouse model of Type 1 diabetes.
In a new study, researchers found that half of the patients they treated for mild COVID-19 infection still had coronavirus for up to eight days after symptoms disappeared.
LodgeNet Interactive Corporation today reported annual 2010 revenue of $452.2 million compared to $484.5 million in 2009. Net loss attributable to common stockholders was $(17.4) million or $(0.71) per share (basic and diluted) for 2010 compared to $(13.3) million or $(0.59) per share (basic and diluted) for 2009.
› Verified 7 days ago
| Entity Name | Kaleida Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366473183 PECOS PAC ID: 7810805280 Enrollment ID: O20031105000212 |
News Archive
Bristol-Myers Squibb (NYSE: BMY) and Enterome SA (Enterome), a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome, announced that they have entered into an Immuno-Oncology focused collaboration agreement for the discovery and development of microbiome-derived biomarkers, drug targets and bioactive molecules to be developed as potential companion diagnostics and therapeutics for cancer.
Researchers at Beth Israel Deaconess Medical Center (BIDMC) have found that a triple combination therapy consisting of both tolerance-inducing and anti-inflammatory properties is successful in abolishing adverse autoimmunity against insulin-producing cells in a mouse model of Type 1 diabetes.
In a new study, researchers found that half of the patients they treated for mild COVID-19 infection still had coronavirus for up to eight days after symptoms disappeared.
LodgeNet Interactive Corporation today reported annual 2010 revenue of $452.2 million compared to $484.5 million in 2009. Net loss attributable to common stockholders was $(17.4) million or $(0.71) per share (basic and diluted) for 2010 compared to $(13.3) million or $(0.59) per share (basic and diluted) for 2009.
› Verified 7 days ago
| Entity Name | Niagara Falls Memorial Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285717298 PECOS PAC ID: 0244134484 Enrollment ID: O20040413001290 |
News Archive
Bristol-Myers Squibb (NYSE: BMY) and Enterome SA (Enterome), a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome, announced that they have entered into an Immuno-Oncology focused collaboration agreement for the discovery and development of microbiome-derived biomarkers, drug targets and bioactive molecules to be developed as potential companion diagnostics and therapeutics for cancer.
Researchers at Beth Israel Deaconess Medical Center (BIDMC) have found that a triple combination therapy consisting of both tolerance-inducing and anti-inflammatory properties is successful in abolishing adverse autoimmunity against insulin-producing cells in a mouse model of Type 1 diabetes.
In a new study, researchers found that half of the patients they treated for mild COVID-19 infection still had coronavirus for up to eight days after symptoms disappeared.
LodgeNet Interactive Corporation today reported annual 2010 revenue of $452.2 million compared to $484.5 million in 2009. Net loss attributable to common stockholders was $(17.4) million or $(0.71) per share (basic and diluted) for 2010 compared to $(13.3) million or $(0.59) per share (basic and diluted) for 2009.
› Verified 7 days ago
| Entity Name | University Orthopaedic Services Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578599866 PECOS PAC ID: 7810983004 Enrollment ID: O20040422001292 |
News Archive
Bristol-Myers Squibb (NYSE: BMY) and Enterome SA (Enterome), a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome, announced that they have entered into an Immuno-Oncology focused collaboration agreement for the discovery and development of microbiome-derived biomarkers, drug targets and bioactive molecules to be developed as potential companion diagnostics and therapeutics for cancer.
Researchers at Beth Israel Deaconess Medical Center (BIDMC) have found that a triple combination therapy consisting of both tolerance-inducing and anti-inflammatory properties is successful in abolishing adverse autoimmunity against insulin-producing cells in a mouse model of Type 1 diabetes.
In a new study, researchers found that half of the patients they treated for mild COVID-19 infection still had coronavirus for up to eight days after symptoms disappeared.
LodgeNet Interactive Corporation today reported annual 2010 revenue of $452.2 million compared to $484.5 million in 2009. Net loss attributable to common stockholders was $(17.4) million or $(0.71) per share (basic and diluted) for 2010 compared to $(13.3) million or $(0.59) per share (basic and diluted) for 2009.
› Verified 7 days ago
| Entity Name | Niagara Falls Memorial Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982659256 PECOS PAC ID: 0244134484 Enrollment ID: O20040524000510 |
News Archive
Bristol-Myers Squibb (NYSE: BMY) and Enterome SA (Enterome), a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome, announced that they have entered into an Immuno-Oncology focused collaboration agreement for the discovery and development of microbiome-derived biomarkers, drug targets and bioactive molecules to be developed as potential companion diagnostics and therapeutics for cancer.
Researchers at Beth Israel Deaconess Medical Center (BIDMC) have found that a triple combination therapy consisting of both tolerance-inducing and anti-inflammatory properties is successful in abolishing adverse autoimmunity against insulin-producing cells in a mouse model of Type 1 diabetes.
In a new study, researchers found that half of the patients they treated for mild COVID-19 infection still had coronavirus for up to eight days after symptoms disappeared.
LodgeNet Interactive Corporation today reported annual 2010 revenue of $452.2 million compared to $484.5 million in 2009. Net loss attributable to common stockholders was $(17.4) million or $(0.71) per share (basic and diluted) for 2010 compared to $(13.3) million or $(0.59) per share (basic and diluted) for 2009.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Scott Nodzo, MD 4225 Genesee St Ste 400, Cheektowaga, NY 14225-1994 Ph: (716) 204-3200 | Dr Scott Nodzo, MD 4949 Harlem Rd, Amherst, NY 14226-2500 Ph: (716) 204-3200 |
News Archive
Bristol-Myers Squibb (NYSE: BMY) and Enterome SA (Enterome), a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome, announced that they have entered into an Immuno-Oncology focused collaboration agreement for the discovery and development of microbiome-derived biomarkers, drug targets and bioactive molecules to be developed as potential companion diagnostics and therapeutics for cancer.
Researchers at Beth Israel Deaconess Medical Center (BIDMC) have found that a triple combination therapy consisting of both tolerance-inducing and anti-inflammatory properties is successful in abolishing adverse autoimmunity against insulin-producing cells in a mouse model of Type 1 diabetes.
In a new study, researchers found that half of the patients they treated for mild COVID-19 infection still had coronavirus for up to eight days after symptoms disappeared.
LodgeNet Interactive Corporation today reported annual 2010 revenue of $452.2 million compared to $484.5 million in 2009. Net loss attributable to common stockholders was $(17.4) million or $(0.71) per share (basic and diluted) for 2010 compared to $(13.3) million or $(0.59) per share (basic and diluted) for 2009.
› Verified 7 days ago
Jeremy Paul Doak, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4949 Harlem Rd, Amherst, NY 14226 Phone: 716-204-3251 Fax: 716-204-3269 | |
Dr. Daniel Vincent Vargo, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3925 Sheridan Dr, Amherst, NY 14226 Phone: 716-250-9999 | |
Michael Ferrick, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 4949 Harlem Rd, Amherst, NY 14226 Phone: 716-204-3251 Fax: 716-204-3269 | |
Marc S Fineberg, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4949 Harlem Rd, 2nd Floor, Amherst, NY 14226 Phone: 716-204-3257 | |
Lisa A Daye, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3925 Sheridan Drive, Suite 100, Amherst, NY 14226 Phone: 716-250-9999 Fax: 716-250-4177 | |
Nicholas Jon-paul Violante, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3925 Sheridan Dr, Amherst, NY 14226 Phone: 716-250-9999 | |
Dr. Kory Benjamin Reed, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3925 Sheridan Dr, Amherst, NY 14226 Phone: 716-250-9999 |